Evidence map›Paper›PMID 35164287›Full record

ArticleMolecules (Basel, Switzerland)2022

Betulonic Acid, as One of the Active Components of the

Zewen Chu, Yuanyuan Luo, Tengyang Ni, Miao Zhu, Xinyi Feng, Yanqing Liu, Haibo Wang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. International journal of molecular sciences · 2024
    Article
  6. Article
  7. Evaluation of theFrontiers in chemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zewen ChuDepartment of Integrated Chinese and Western Medicine, Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Yuanyuan LuoDepartment of Integrated Chinese and Western Medicine, Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Tengyang NiDepartment of Integrated Chinese and Western Medicine, Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Miao ZhuDepartment of Integrated Chinese and Western Medicine, Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Xinyi FengDepartment of Integrated Chinese and Western Medicine, Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Yanqing LiuDepartment of Integrated Chinese and Western Medicine, Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Haibo WangDepartment of Integrated Chinese and Western Medicine, Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.ORCID 0000-0002-7549-5613
State Administration of Traditional Chinese Medicine of the People's Republic of China · CNYangzhou University · CN

Funding

Jiangsu Graduate Scientific Research Innovation Program KYCX21_3295National Nature Science Foundation of China 81773944National Nature Science Foundation of China 82104946Natural Science Foundation of Jiangsu Province BK20210817The Traditional Chinese Medicine Science and Technology Development Project of Jiangsu Province QN202008
6 · The paper itself

Abstract

Gastric cancer is a type of malignant tumor that seriously threatens human life and health. Invasion and metastasis present difficulties in the treatment of gastric cancer, and the remodeling of the tumor cytoskeleton plays an important role in mediating the ability of tumor cells to achieve invasion and metastasis. Previous experimental results suggest that

Indexed as

CelastrusAntineoplastic Agents, PhytogenicBetulinic AcidCell Line, TumorCytoskeletonHumansNeoplasm InvasivenessOleanolic AcidStomach NeoplasmsAntineoplastic Agents, PhytogenicBetulinic Acidbetulonic acidOleanolic AcidCelastrus orbiculatuscytoskeleton rearrangementEMTMMP

Identifiers

PMID35164287
PMCPMC8840099
OpenAlexW4210527037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.